Mad cow disease test in development - New tests - Caprion Pharmaceuticals Inc - OrthoClinical Diagnostics Inc - Brief Article

Medical Laboratory Observer, Feb, 2002

> A new licensing agreement between OrthoClinical Diagnostics Inc, (OCD) and Caprion Pharmaceuticals Inc. focuses on the development of a human blood test for variant Creutzfield-Jacob disease (vCJD), the human equivalent of mad cow disease. OCD, a Johnson & Johnson Co. based in Raritan, NJ, has been collaborating with Montreal-based Caprion on their prion technologies, including their unique monoclonal antibodies for detection of the agent responsible for vCJD.